Sridevi N Dhanaraj

This inventor holds 37 USPTO granted patents and 18 published patent applications, plus 4 CIPO patents and 20 EPO patents, primarily in Biocompatible Sealants. Top assignees: Ethicon, Gmbh, Depuy Synthes Products, Inc., Omrix Biopharmaceuticals Inc.. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sridevi N Dhanaraj. Retrieved from https://idiyas.com/inventor/sridevi-n-dhanaraj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 37 (Patent Applications = 18)

% Patents Active = 75.7

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 20 (Patent Applications = 26)

Average Co-Inventor Count = 4.5

ph-index = 8

Forward Citations = 2,706(Granted Patents)

Location History:

Somerset, NJ (US) (2004 - 2007)
Somerville, NJ (US) (2019)
Raritan, NJ (US) (2007 - 2024)

Company Filing History:

Depuy Synthes Products, Inc.

patents

6 out of 108

Omrix Biopharmaceuticals Inc.

Janssen Pharmaceutica Nv

patents

6. 2 out of 20

Advanced Technologies and Regenerative Medicine, LLC

where one patent can have more than one assignee

Years Active: 2004-2026

Loading Chart...

Areas of Expertise:

Biodegradable Sealants

Hemostatic Compositions

Biocompatible Scaffolds

Tissue Repair

Vascular Growth Factors

Cartilage Regeneration

Synthetic Matrices

Tissue Engineering

Flowable Hemostats

Cellulose Fibers

Urological Repair

Bioabsorbable Scaffolds

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12599624 - Biodegradable lung sealants (2026-04-14),

2. 12576183 - Methods and devices for changing the flow rates of pH modifying fluids for controlling cross-linking rates of reactive components of biocompatible sealing compositions (2026-03-17),

3. 12539374 - Systems, devices and methods for dispensing biocompatible reactive formulations and controlling cross-linking of the reactive components of the biocompatible reactive formulations (2026-02-03),

4. 12415015 - Kit for composition for tissue tract sealing (2025-09-16),

5. 12220118 - Systems, devices and methods for reconstituting therapeutic powders, mixing precursor solutions, and expressing sealants for controlling bleeding and sealing fluid and air leaks (2025-02-11),

6. 11957326 - Variable length telescoping application tips for flowable hemostats and sealants application (2024-04-16),

7. 11826028 - Two component sealing systems including synthetic matrices and biosynthetic adhesives for sealing resected surfaces of organs to control bleeding, fluid leaks and air leaks (2023-11-28),

8. 11712495 - Hemostatic mixture of cellulose-based short and long fibers (2023-08-01),

9. 11395865 - Scaffolds with viable tissue (2022-07-26),

10. 11191789 - Cartilage and bone repair and regeneration using postpartum-derived cells (2021-12-07),

11. 11179422 - Method of differentiating umbilical cord tissue into a chondrogenic phenotype (2021-11-23),

12. 11007301 - Hemostatic mixture of cellulose-based short and long fibers (2021-05-18),

13. 11007300 - Hemostatic composition (2021-05-18),

14. 10980913 - Sealant foam compositions for lung applications (2021-04-20),

15. 10960105 - Hemostatic composition (2021-03-30),

Title: Innovations by Sridevi N Dhanaraj in Therapeutic Delivery Systems

Introduction

Sridevi N Dhanaraj, based in Somerset, NJ, is a prominent inventor with a remarkable portfolio of 33 patents. His contributions to the field of medical devices, particularly in therapeutic delivery systems, have significantly advanced methodologies in treating patients effectively.

Latest Patents

Among his latest innovations are a series of patents focused on systems, devices, and methods for reconstituting therapeutic powders, mixing precursor solutions, and expressing sealants for controlling bleeding and sealing fluid and air leaks. One of his notable inventions is a sealant delivery system that employs a syringe assembly featuring side-by-side syringes alongside a vial assembly. This system is designed for precision in sealing applications, offering a mechanism that enables fluid communication through piercing elements between a syringe and its respective vials.

Additionally, another important patent details a variable-length applicator system for delivering medically useful liquids. This invention consists of an elongated, telescopically extendable cannula with a connected liquid pump and a spray nozzle. The design allows for a coiled and extendable tubular conduit to maintain fluid communication during axial extension, presenting a highly adaptable solution for healthcare professionals.

Career Highlights

Sridevi has had a distinguished career, working with leading companies in the medical sector. He has made significant contributions during his tenure at Ethicon, GmbH, and Omrix Biopharmaceuticals Inc. His experience and expertise in developing innovative medical technologies have been pivotal in shaping modern therapeutic solutions.

Collaborations

Throughout his career, Sridevi has collaborated with talented professionals such as Anna Gosiewska and Erez Ilan. These partnerships have facilitated the exchange of ideas and have led to the development of cutting-edge inventions that improve patient care and outcomes.

Conclusion

Sridevi N Dhanaraj stands out as a pioneering inventor in the realm of therapeutic delivery systems. His 33 patents are a testament to his dedication and innovative spirit, driving advancements in healthcare technology that will benefit countless patients. As he continues to explore new frontiers in invention, his work will undoubtedly have a lasting impact on the medical field.

Profile summary based on public USPTO records.